Company Long-Term Debt: Agilent Corp (A)

Brandmark of Agilent Tech (A)

Agilent Technologies (A) is considered the benchmark for precision in the laboratory equipment sector. An analysis of the company's long-term debt on the GURU.Markets chart shows that the indicator remains around 3.66. Stability is ensured by management's prudent capital allocation and an academic culture that attracts leading R&D engineers. This approach allows Agilent Technologies to maintain its operating margin while developing cutting-edge diagnostic solutions.

Agilent (A) Company Long-Term Debt: for the period 07/04/2022 - 10/29/2026

Summary analytical data breakdowns for Agilent Tech (A)

- market price and analyst price targets:
Stock Price agilent.com|A - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Agilent|A - Real Price to Acquire Entire Company
- business book valuation details:
Net Asset Value per Share Agilent|A - Company Book Value|Market Capitalization to Book Value agilent.com|A - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient Agilent Technologies|A - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Agilent Corp|A - Company Aggregate Debts|Debts to Book Capitalization Agilent|A - Company Long-Term Debts|Short-Term Indebtedness Agilent
Summary company analytics:A (agilent.com)
Signature product of Agilent Technologies

Long-term debt reflects the total credit obligations with a maturity of more than one year. This metric is calculated based on consolidated financial statements, capturing the volume of borrowed capital used for strategic development. By analyzing the company's current level of long-term debt, an investor assesses the balance between financial risks and investment potential. For Agilent Technologies (A), such funds are critical for establishing high-tech laboratories and supporting academic R&D research.

Who Agilent Technologies competes with

Company Long-Term Debts questdiagnostics.com DGX|ILMN - Company Long-Term Debt|EXAS: Company Long-Term Debt|RVTY (PerkinElmer) - Company Long-Term Liabilities|Long-Term Debt Bio-Rad Corp (BIO)|Company Long-Term Debt Anbio Biotechnology|soterahealth.com (SHC) - Long-Term Debt Volume|Company Long-Term Debts QDEL|Long-Term Debt Volume OPKO Health Inc|Company Long-Term Debt caredx.com CDNA|Long-Term Debt Volume Maravai (MRVI)|Fulgent Genetics, Inc. - Company Long-Term Debts|LAB - Company Long-Term Debts|CTKB: Company Long-Term Debts|Long-Term Indebtedness OraSure Technologies, Inc. OSUR|XGN (Exagen Inc) - Company Long-Term Debts|MDxHealth, Inc. (MDXH) - Long-Term Debt Volume|Company Long-Term Debt Lucid Diagnostics Inc. (LUCD)|Company Long-Term Debt PRE (prenetics.com)|Company Long-Term Debts IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC (TRIB) - Long-Term Debt|PRPH - Company Long-Term Debt|AIMD (Ainos Corporation) - Company Long-Term Indebtedness|CODX (Co-Diagnostics, Inc.) - Company Long-Term Liabilities|HSCS: Amount of Long-Term Liabilities|Company Long-Term Liabilities BMRA|CDIO: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities VRAX (Virax Biolabs Group Ltd)|Amount of Long-Term Liabilities BJDX|Company Long-Term Debts AWH (Aspira Women's Health)|acceleratediagnostics.com (AXDX) - Long-Term Debt|CENTOGENE - Company Long-Term Debts|Enzo Biochem, Inc. (ENZ) - Company Long-Term Liabilities|FRES: Company Long-Term Debts|Genetic Technologies Limited - Company Long-Term Loans and Borrowings|Company Long-Term Debt 23andMe Holding Co.|Company Long-Term Indebtedness PMD (psychemedics.com)